CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Operating Income Growth by Quarter and Year

Mateon Therapeutics Inc's Operating Income results by quarter and year




OXGN Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.54 -0.90 -3.90
III Quarter September - -0.93 -0.80 -3.97
II Quarter June 0.01 -1.16 -2.44 -3.14
I Quarter March -2.65 -0.68 -3.54 -3.67
FY   -2.64 -4.31 -7.68 -14.68



OXGN Operating Income second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved Operating Income of $ 0.01 millions compare to Operating Loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Operating Income no change of % ranks overall at the positon no. 0 in the second quarter.

Explain Operating Income growth


OXGN Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Operating Income $ 0.01 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Operating Income $ -1.16 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Operating Income Growth >>


OXGN Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Operating Income Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc published Operating Income of $ 0.01 millions should be beginning of positive performance.Mateon Therapeutics Inc announced in the II. Quarter 2020 Operating Income of $ 0.01 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Operating Income growth. While Mateon Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is 0.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Operating Income Comment
Improvement II. Quarter 2020where Mateon Therapeutics Inc posted Operating Income of $ 0.01 millions may be considered as a starting point of improved performance.Mateon Therapeutics Inc announced in the II. Quarter 2020 Operating Income of $ 0.01 millions compare to Operating Loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Operating Income growth. While Mateon Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is 0.


Mateon Therapeutics Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Operating Income 12 Months Ending $ -5.10 $ -6.28 $ -4.31 $ -3.67 $ -3.53
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
OXGN's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for OXGN's Competitors
Operating Income Growth for Mateon Therapeutics Inc's Suppliers
Operating Income Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2020
Charles River Laboratories International inc -3.76 %$ -3.761 millions
Mettler Toledo International Inc -4.02 %$ -4.018 millions
Select Medical Holdings Corp -4.30 %$ -4.295 millions
Hca Healthcare Inc -4.96 %$ -4.962 millions
Catalyst Pharmaceuticals Inc -6.18 %$ -6.180 millions
Baxter International Inc -6.76 %$ -6.761 millions
Vanda Pharmaceuticals Inc -7.32 %$ -7.317 millions
Quest Diagnostics Inc -7.82 %$ -7.818 millions
Merck and Co Inc -7.94 %$ -7.944 millions
Bio rad Laboratories Inc -8.24 %$ -8.243 millions
Atrion Corporation -8.39 %$ -8.390 millions
National Research Corporation -8.61 %$ -8.612 millions
Bio techne Corp -9.14 %$ -9.139 millions
Davita Inc -11.25 %$ -11.251 millions
Laboratory Corporation Of America Holdings -11.32 %$ -11.320 millions
Msa Safety Inc -11.35 %$ -11.351 millions
Apollo Medical Holdings Inc -12.38 %$ -12.376 millions
Electromed Inc -13.17 %$ -13.165 millions
Medpace Holdings inc -14.55 %$ -14.552 millions
Acadia Healthcare Company Inc -16.51 %$ -16.512 millions
Encompass Health Corporation -17.62 %$ -17.624 millions
Lemaitre Vascular Inc -17.63 %$ -17.633 millions
Surgery Partners Inc -19.46 %$ -19.459 millions
Eli Lilly And Company -20.12 %$ -20.123 millions
Genesis Healthcare inc -22.40 %$ -22.398 millions
Johnson and Johnson -25.46 %$ -25.462 millions
Icu Medical Inc -25.55 %$ -25.546 millions
Pfizer Inc -27.54 %$ -27.543 millions
Bruker Corporation -29.16 %$ -29.159 millions
Healthcare Services Group Inc -29.20 %$ -29.203 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PPCH's Profile

Stock Price

PPCH's Financials

Business Description

Fundamentals

Charts & Quotes

PPCH's News

Suppliers

PPCH's Competitors

Customers & Markets

Economic Indicators

PPCH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071